CID 16133603

5'-td[ccgaagacg]-3', phosphorothioate oligodeoxynucleotide

Structural Information

Molecular Formula
C97H122N41O47P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)OP(=S)(O)OCC3C(CC(O3)N4C=CC(=NC4=O)N)OP(=S)(O)OCC5C(CC(O5)N6C=CC(=NC6=O)N)OP(=S)(O)OCC7C(CC(O7)N8C=NC9=C8N=C(NC9=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O)S
InChI
InChI=1S/C97H122N41O47P9S9/c1-38-18-132(97(148)128-87(38)141)66-9-40(49(19-139)167-66)177-187(150,196)159-21-51-42(11-64(169-51)130-6-3-60(99)120-95(130)146)179-188(151,197)160-23-53-43(12-65(171-53)131-7-4-61(100)121-96(131)147)180-189(152,198)165-27-57-47(16-70(175-57)137-36-117-76-85(137)123-92(105)126-89(76)143)184-193(156,202)164-26-56-45(14-68(174-56)134-33-114-73-79(102)108-30-111-82(73)134)182-191(154,200)162-24-54-46(15-69(172-54)135-34-115-74-80(103)109-31-112-83(74)135)183-192(155,201)166-28-58-48(17-71(176-58)138-37-118-77-86(138)124-93(106)127-90(77)144)185-194(157,203)163-25-55-44(13-67(173-55)133-32-113-72-78(101)107-29-110-81(72)133)181-190(153,199)161-22-52-41(10-63(170-52)129-5-2-59(98)119-94(129)145)178-186(149,195)158-20-50-39(140)8-62(168-50)136-35-116-75-84(136)122-91(104)125-88(75)142/h2-7,18,29-37,39-58,62-71,139-140H,8-17,19-28H2,1H3,(H,149,195)(H,150,196)(H,151,197)(H,152,198)(H,153,199)(H,154,200)(H,155,201)(H,156,202)(H,157,203)(H2,98,119,145)(H2,99,120,146)(H2,100,121,147)(H2,101,107,110)(H2,102,108,111)(H2,103,109,112)(H,128,141,148)(H3,104,122,125,142)(H3,105,123,126,143)(H3,106,124,127,144)
InChIKey
HLPHYSPVRZBRKL-UHFFFAOYSA-N
Compound name
1-[4-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-sulfanylphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

3179.3542 Da
Monoisotopic Mass

-5.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3180.3615 295.6
[M+Na]+ 3202.3434 298.6
[M-H]- 3178.3469 295.9
[M+NH4]+ 3197.3880 296.7
[M+K]+ 3218.3174 297.2
[M+H-H2O]+ 3162.3515 296.0
[M+HCOO]- 3224.3524 296.9
[M+CH3COO]- 3238.3681 297.3
[M+Na-2H]- 3200.3289 299.7
[M]+ 3179.3537 298.8
[M]- 3179.3547 298.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.